These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26893210)

  • 1. Improvement of autism spectrum disorder symptoms in three children by using gastrin-releasing peptide.
    Becker MM; Bosa C; Oliveira-Freitas VL; Goldim JR; Ohlweiler L; Roesler R; Schwartsmann G; Riesgo Rdos S
    J Pediatr (Rio J); 2016; 92(3):302-6. PubMed ID: 26893210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in Symptoms of Autism Spectrum Disorder in Children With the Use of Gastrin-Releasing Peptide: An Open Trial.
    Becker MM; Riesgo RS; Roesler R; Bosa C; Ohlweiler L; Backes B; Endres RG; Zanon RB; Marchezan J; Schwartsmann G
    Clin Neuropharmacol; 2016; 39(5):215-9. PubMed ID: 27332629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Placebo-Controlled Crossover Trial of Gastrin-Releasing Peptide in Childhood Autism.
    Marchezan J; Becker M; Schwartsmann G; Ohlweiler L; Roesler R; Renck LB; Gonçalves MMM; Ranzan J; Riesgo RDS
    Clin Neuropharmacol; 2017; 40(3):108-112. PubMed ID: 28452904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder.
    Saad K; Abdel-Rahman AA; Elserogy YM; Al-Atram AA; El-Houfey AA; Othman HA; Bjørklund G; Jia F; Urbina MA; Abo-Elela MGM; Ahmad FA; Abd El-Baseer KA; Ahmed AE; Abdel-Salam AM
    J Child Psychol Psychiatry; 2018 Jan; 59(1):20-29. PubMed ID: 27868194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
    Lee SH; Shin S; Kim TH; Kim SM; Do TY; Park S; Lee B; Shin HJ; Lee J; Lee JY; Chang GT
    Trials; 2019 Jul; 20(1):434. PubMed ID: 31307524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved symptoms following bumetanide treatment in children aged 3-6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial.
    Dai Y; Zhang L; Yu J; Zhou X; He H; Ji Y; Wang K; Du X; Liu X; Tang Y; Deng S; Langley C; Li WG; Zhang J; Feng J; Sahakian BJ; Luo Q; Li F
    Sci Bull (Beijing); 2021 Aug; 66(15):1591-1598. PubMed ID: 36654288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.
    Lightdale JR; Hayer C; Duer A; Lind-White C; Jenkins S; Siegel B; Elliott GR; Heyman MB
    Pediatrics; 2001 Nov; 108(5):E90. PubMed ID: 11694674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials.
    James BJ; Gales MA; Gales BJ
    Ann Pharmacother; 2019 May; 53(5):537-544. PubMed ID: 30501497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
    Lemonnier E; Villeneuve N; Sonie S; Serret S; Rosier A; Roue M; Brosset P; Viellard M; Bernoux D; Rondeau S; Thummler S; Ravel D; Ben-Ari Y
    Transl Psychiatry; 2017 Mar; 7(3):e1056. PubMed ID: 28291262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
    Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation.
    Melamed IR; Heffron M; Testori A; Lipe K
    Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder.
    Scahill L; Bearss K; Sarhangian R; McDougle CJ; Arnold LE; Aman MG; McCracken JT; Tierney E; Gillespie S; Postorino V; Vitiello B
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):125-131. PubMed ID: 27893955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences Between the Childhood Autism Rating Scale and the Social Responsiveness Scale in Assessing Symptoms of Children with Autistic Spectrum Disorder.
    Chen KL; Lin CH; Yu TY; Huang CY; Chen YD
    J Autism Dev Disord; 2018 Sep; 48(9):3191-3198. PubMed ID: 29696524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L1-79 on Core Symptoms of Autism Spectrum Disorder: A Case Series.
    Rothman J; Bartky EJ; Halas FP
    Clin Ther; 2019 Oct; 41(10):1972-1981. PubMed ID: 31492568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Placebo-Controlled Trial of Methyl B12 for Children with Autism.
    Hendren RL; James SJ; Widjaja F; Lawton B; Rosenblatt A; Bent S
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):774-783. PubMed ID: 26889605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of cerebrolysin in the treatment of autism spectrum disorders].
    Chutko LS; Yakovenko EA; Surushkina SY; Kryukova EM; Palaieva SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):71-75. PubMed ID: 29053124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Antipsychotic Medication Use in Autism Spectrum Disorder.
    Wink LK; Pedapati EV; Horn PS; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):91-94. PubMed ID: 26465194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
    Desjardins S; Doyen C; Contejean Y; Kaye K; Paubel P
    Encephale; 2009 Apr; 35(2):168-72. PubMed ID: 19393386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.
    Frye RE; Slattery J; Delhey L; Furgerson B; Strickland T; Tippett M; Sailey A; Wynne R; Rose S; Melnyk S; Jill James S; Sequeira JM; Quadros EV
    Mol Psychiatry; 2018 Feb; 23(2):247-256. PubMed ID: 27752075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.